Homozygous mice with mutant protein FUS[1-359] overexpression: Innovative possibilities for ALS treatment
Introduction: This study investigates a mouse model with overexpression of the mutant FUS[1-359] protein, which can be used to evaluate the effectiveness of gene therapy and other pharmacological interventions for amyotrophic lateral sclerosis (ALS). The model enhances the deeper understanding of th...
Saved in:
Main Author: | Nikita S. Zhunusov |
---|---|
Format: | Article |
Language: | English |
Published: |
Belgorod National Research University
2024-12-01
|
Series: | Research Results in Pharmacology |
Subjects: | |
Online Access: | https://rrpharmacology.ru/index.php/journal/article/view/554 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Whole blood transcriptome profile identifies motor neurone disease RNA biomarker signatures
by: Sulev Kõks, et al.
Published: (2025-01-01) -
Optineurin overexpression ameliorates neurodegeneration through regulating neuroinflammation and mitochondrial quality in a murine model of amyotrophic lateral sclerosis
by: Shumin Zhao, et al.
Published: (2025-02-01) -
Evaluation of Dysphagia in Amyotrophic Lateral Sclerosis
by: Xiao QIU, et al.
Published: (2017-02-01) -
Associations of cachexia and frailty with amyotrophic lateral sclerosis
by: Tracy L. Peters, et al.
Published: (2025-02-01) -
Direct and Indirect Protein Interactions Link FUS Aggregation to Histone Post-Translational Modification Dysregulation and Growth Suppression in an ALS/FTD Yeast Model
by: Seth A. Bennett, et al.
Published: (2025-01-01)